NCT04337138View on ClinicalTrials.gov

A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

April 7, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Leukemia, Myeloid, Acute
Interventions
DRUG

Gemtuzumab Ozogamicin

Gemtuzumab Ozogamicin (Mylotarg) administered in any form or combination

Trial Locations (1)

10017

Pfizer Investigational Site, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY